Melanocortins As Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|6|735-750

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.6, 2013-02, pp. : 735-750

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiapoptotic Drugs: A Therapautic Strategy for the Prevention of Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 3, 2011-01 ,pp. : 230-245

Bentham Science Publishers

Access to resources Recommend Favorite

Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 807-812

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1513-1529

Bentham Science Publishers

Access to resources Recommend Favorite

AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives

By  

Current Drug Targets, Vol. 17, Iss. 8, 2016-06 ,pp. : 890-907

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Inflammatory Drugs in the Treatment of Neurodegenerative Diseases: Current State

By  

Current Pharmaceutical Design, Vol. 12, Iss. 27, 2006-09 ,pp. : 3509-3519

Bentham Science Publishers

Access to resources Recommend Favorite